Nanotechnology-Based Drug Delivery Systems in the Transdermal Treatment of Melanoma
Advanced Pharmaceutical Bulletin · 01.11.2023 · 13 (4) · 646-662
DOI: 10.34172/apb.2023.070 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Pharmaceutical Bulletin, online erschienen am 23.01.2023. Verfasst von Zahra Saeidi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The incidence rate of melanoma is dramatically increasing worldwide, raising it to the fifth most common cancer in men and the sixth in women currently. Resistance generally occurs to the agents used in chemotherapy; besides their high toxicity destroys the normal cells. This study reviewed a detailed summary of the structure, advantages, and disadvantages of nanotechnology-based drug delivery systems in the treatment of melanoma, as well as some nanocarrier applications in animal models or clinical studies. Respective databases were searched for the target keywords and 93 articles were reviewed and discussed. A close study of the liposomes, niosomes, transferosomes, ethosomes, transethosomes, cubosomes, dendrimers, cyclodextrins, solid lipid nanoparticles, and carbon nanotubes (CNTs) was conducted. It was found that these nanocarriers could inhibit metastasis and migration of melanoma cells and decrease cell viability. Conclusively, some nanocarriers like liposomes, niosomes, and transferosomes have been discussed as superior to conventional therapies for melanoma treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutics, School of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
- Department of Prosthodontics, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.
ORCID-Profile: Zahra Saeidi, Farhad Mohammadi
Zitieren
APA
Saeidi, Z., Giti, R., Rostami, M., & Mohammadi, F. (2023). Nanotechnology-Based Drug Delivery Systems in the Transdermal Treatment of Melanoma. Advanced Pharmaceutical Bulletin, 13(4), 646-662. https://doi.org/10.34172/apb.2023.070
Vancouver
Saeidi Z, Giti R, Rostami M, Mohammadi F. Nanotechnology-Based Drug Delivery Systems in the Transdermal Treatment of Melanoma. Advanced Pharmaceutical Bulletin. 2023;13(4):646-662. doi:10.34172/apb.2023.070
BibTeX
@article{Saeidi2023,
author = {Saeidi, Zahra and Giti, Rashin and Rostami, Mehdi and Mohammadi, Farhad},
title = {Nanotechnology-Based Drug Delivery Systems in the Transdermal Treatment of Melanoma},
journal = {Advanced Pharmaceutical Bulletin},
year = {2023},
volume = {13},
number = {4},
pages = {646--662},
doi = {10.34172/apb.2023.070}
}
EUVIMED